Insights

Strategic Partnerships Antidote has recently integrated with Seqster for operating system capabilities to enhance recruitment and patient engagement in clinical trials, indicating openness to partnerships that broaden platform capabilities and reach.

diabetes Focus Active collaborations with Beyond Type 1 and JDRF highlight a strong focus on diabetes research engagement, suggesting opportunities to tailor recruitment solutions and patient journeys for diabetes studies.

Awards & Reputation Multiple recognitions including EcoVadis Silver and an Improving Lives Benefit Corporate Honoree bolster credibility with sponsors and CROs, easing conversations on risk, ethics, and impact for prospective clients.

Cybersecurity Maturity CyberGRX cybersecurity risk assessment completed with high scores signals a robust security posture, a key differentiator when selling to large biopharma and research organizations prioritizing data protection.

Scale Readiness Revenue in the lower-mid multi-million range with a lean team (11-50 employees) and a track record of specialized patient recruitment helps identify mid-market biopharma sponsors seeking focused, agile clinical trial recruitment partners.

Antidote Technologies Tech Stack

Antidote Technologies uses 8 technology products and services including Kubernetes, OneTrust, Salesforce, and more. Explore Antidote Technologies's tech stack below.

Media & News

Antidote Technologies's Email Address Formats

Antidote Technologies uses at least 1 format(s):
Antidote Technologies Email FormatsExamplePercentage
First.Last@antidote.meJohn.Doe@antidote.me
69%
First@antidote.meJohn@antidote.me
25%
FLast@antidote.meJDoe@antidote.me
3%
Fir.Last@antidote.meJoh.Doe@antidote.me
3%

Frequently Asked Questions

What is Antidote Technologies's official website and social media links?

Minus sign iconPlus sign icon
Antidote Technologies's official website is antidote.me and has social profiles on LinkedInCrunchbase.

How much revenue does Antidote Technologies generate?

Minus sign iconPlus sign icon
As of August 2026, Antidote Technologies's annual revenue is estimated to be $1M - $10M.

What is Antidote Technologies's NAICS code?

Minus sign iconPlus sign icon
Antidote Technologies's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Antidote Technologies have currently?

Minus sign iconPlus sign icon
As of August 2026, Antidote Technologies has approximately 23 employees across 3 continents, including North AmericaEuropeAsia. Key team members include President & Founder: D. M.Head Of Communications And Demand Generation: L. C.Company Director: D. C.. Explore Antidote Technologies's employee directory with LeadIQ.

What industry does Antidote Technologies belong to?

Minus sign iconPlus sign icon
Antidote Technologies operates in the Research Services industry.

What technology does Antidote Technologies use?

Minus sign iconPlus sign icon
Antidote Technologies's tech stack includes KubernetesOneTrustSalesforcePostgreSQLGoogle CloudAtlassian JiraDocuSignElasticsearch.

What is Antidote Technologies's email format?

Minus sign iconPlus sign icon
Antidote Technologies's email format typically follows the pattern of First.Last@antidote.me. Find more Antidote Technologies email formats with LeadIQ.

How much funding has Antidote Technologies raised to date?

Minus sign iconPlus sign icon
As of August 2026, Antidote Technologies has raised $52M in funding. The last funding round occurred on Jun 03, 2021 for $23M.

When was Antidote Technologies founded?

Minus sign iconPlus sign icon
Antidote Technologies was founded in 2010.
Antidote Technologies logo

Antidote Technologies

Research ServicesFlorida, United States11-50 Employees

Antidote Technologies operates in the research services sector, focusing on clinical trial recruitment and patient engagement. It aims to connect patients with researchers to support participation in medical studies, helping to facilitate the clinical research process. The company is based in Miami, Florida, and has a mid-sized team.

Antidote traces its history to 2010, when it launched as TrialReach, and it rebranded to Antidote in 2016. A recent development is the July 2024 integration with Seqster PDM, Inc., a collaboration that combines Seqster's operating system with Antidote's recruitment and engagement capabilities. This places Antidote within the patient-centric digital engagement space of clinical research, serving researchers and sponsors seeking to connect with eligible participants.

Section iconCompany Overview

NAICS Code
5417 - Scientific Research and Development Services
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $52M

    Antidote Technologies has raised a total of $52M of funding over 6 rounds. Their latest funding round was raised on Jun 03, 2021 in the amount of $23Mas a series_unknown.

  • $1M - $10M

    Antidote Technologies's revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $52M

    Antidote Technologies has raised a total of $52M of funding over 6 rounds. Their latest funding round was raised on Jun 03, 2021 in the amount of $23Mas a series_unknown.

  • $1M - $10M

    Antidote Technologies's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.